Share:
Peer-Reviewed Publication
Diabetes Res Clin Pract2026;113450.July 17, 2026Journal Article

Simplifying meal bolusing with Omnipod 5: real-world outcomes to support simplified user-initiated insulin dosing strategies in managing type 1 or type 2 diabetes.

Georgia M Davis1, Gregory P Forlenza2, Bernhard Gehr3, John Pemberton4, Alfred Penfornis5, Duy Do6, Lauren M Huyett7, Trang T Ly8
1Emory University School of Medicine, 100 Woodruff Circle, Atlanta, GA, United States. Electronic address: georgia.marie.davis@emory.edu.
2Department of Pediatrics, Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, 1775 Aurora Ct, Suite A140, Aurora, CO 80045, United States. Electronic address: gregory.forlenza@cuanschutz.edu.
3m&i Specialist Hospital Bad Heilbrunn, Center for Diabetes and Metabolism, Wörnerweg 30, 83670 Bad Heilbrunn, Germany. Electronic address: bernhard.gehr@fachklinik-bad-heilbrunn.de.
4Diabetes & Endocrinology, Birmingham Women's and Children's NHS Foundation Trust, Mindelsohn Way, Birmingham B15 2TG, United Kingdom. Electronic address: johnpemberton@nhs.net.
5Hospital Center Sud Francilien, 40 Avenue Serge Dassault, 91100 Corbeil-Essonnes, France; Paris-Saclay University, 63 Rue Gabriel Péri, 94270 Le Kremlin-Bicêtre, France. Electronic address: alfred.penfornis@chsf.fr.
6Insulet Corporation, 100 Nagog Park, Acton, MA 01720, United States. Electronic address: ddo@insulet.com.
7Insulet Corporation, 100 Nagog Park, Acton, MA 01720, United States. Electronic address: lhuyett@insulet.com.
8Insulet Corporation, 100 Nagog Park, Acton, MA 01720, United States. Electronic address: tly@insulet.com.

Abstract

AIMS: Automated insulin delivery (AID) systems typically require user‑initiated meal boluses. This study leveraged real-world data from Omnipod® 5 Automated Insulin Delivery System users to evaluate whether glycemic outcomes using simplified meal bolusing were non-inferior to carbohydrate counting. METHODS: A retrospective analysis of Omnipod 5 users in the US, UK, France, and Germany from 01/01/…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.